Your browser is no longer supported. Please, upgrade your browser.
PJP Invesco Dynamic Pharmaceuticals ETF daily Stock Chart
Invesco Dynamic Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.38%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month6.21%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter10.10%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y8.48%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-4.09%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range54.86 - 69.38 Perf YTD2.63%
Dividend0.70 P/FCF- EPS past 5Y- ROI- 52W High-7.77% Beta-
Dividend %1.09% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low16.64% ATR0.63
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)71.56 Volatility0.90% 0.89%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.47 Prev Close63.75
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume35.82K Price63.99
Recom- SMA203.03% SMA507.45% SMA2006.18% Volume16,929 Change0.38%
Dec-05-19 01:52PM  Pelosis drug-pricing bill likely to pass House next week, but pharma stocks are up as its unlikely to become law MarketWatch
Nov-08-19 08:00AM  Pharma Sector Tops in October: Best ETFs & Stocks Zacks
Nov-06-19 11:00AM  Pharma ETFs Set to Benefit Post Strong Q3 Earnings Zacks
Oct-15-19 11:53AM  Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts InvestorPlace
Sep-20-19 09:01AM  Pelosi says she hopes for Trumps support as she unveils plan to lower drug prices MarketWatch
Sep-11-19 04:43PM  Potential Peanut Allergy Treatment Gives Pharma Company A Boost ETF Trends
Aug-27-19 10:05AM  Amgen to Buy Celgene's Otezla: 5 ETF Drugs Zacks
Aug-22-19 11:12AM  8 ETFs to Capture Opportunities in Healthcare Sector ETF Trends
Aug-07-19 10:59AM  Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? Zacks
Jul-24-19 12:15PM  7 Bad ETFs That Just Arent Worth the Trouble This Year InvestorPlace
Jul-14-19 11:00AM  4 Hot Pharmaceutical ETFs ETF Trends
Jul-09-19 04:18PM  Drug Pricing War: Pharma, Biotech Stocks Score A Win Over Trump Investor's Business Daily
Jun-26-19 11:00AM  AbbVie to Buy Allergan: Prescribed ETFs Zacks
Jun-25-19 06:01PM  AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs ETF Trends
May-14-19 05:40PM  Legal Troubles Beset Pharmaceutical Sector ETFs ETF Trends
May-09-19 10:05AM  Pharma ETFs Down Despite Solid Q1 Results Zacks
Apr-09-19 02:14PM  4 ETFs to Consider with Big Pharma on the Senates Hot Seat ETF Trends
Mar-08-19 08:00AM  4 Sector ETFs That Crushed S&P 500 in Decade-Old Bull Run Zacks
Mar-01-19 08:00AM  Why These Pharma ETFs Rallied on Thursday Zacks
Feb-28-19 04:43PM  Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results ETF Trends
Feb-21-19 10:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Feb-07-19 11:15AM  A Look at Pharma ETFs Post Q4 Results Zacks
Jan-29-19 09:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Jan-07-19 09:27AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Jan-04-19 10:01AM  Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus Zacks
Dec-14-18 09:28AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Oct-24-18 11:59AM  ETF Strategies for the Midterm Elections Zacks
Oct-22-18 03:30PM  ETF Plays for a Divided Midterm Elections ETF Trends
Oct-12-18 06:00AM  Top 5 Pharmaceutical ETFs for 2018 Investopedia
Oct-09-18 11:39AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Sep-06-18 04:56PM  Pharmaceutical ETFs Could Maintain Their Momentum ETF Trends
Aug-12-18 04:56AM  Is Projprzem SAs (WSE:PJP) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Aug-02-18 10:47AM  5 Strong Healthcare ETFs to Buy InvestorPlace
Jul-03-18 03:19PM  July Could Be a Volatile Month for Pharma ETFs ETF Trends
Jun-11-18 03:23PM  Best Sector ETFs of Last Week Zacks
Jun-08-18 04:01PM  Play the Best Sector of Summer With These ETFs & Stocks Zacks
May-18-18 08:15AM  Who Are Projprzem SA.s (WSE:PJP) Major Shareholders? Simply Wall St.
May-11-18 04:18PM  6 Top Healthcare ETFs Rally as Trump Vows End to Global Freeloading ETF Trends
May-10-18 11:03AM  Does Projprzem SA.s (WSE:PJP) PE Ratio Signal A Buying Opportunity? Simply Wall St.
Apr-24-18 06:41AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Apr-20-18 12:38PM  Projprzem SA. (WSE:PJP) Delivered A Better ROE Than The Industry, Heres Why Simply Wall St.
Apr-13-18 09:15AM  Is Projprzem SA. (WSE:PJP) A Financially Sound Company? Simply Wall St.
Mar-24-18 10:47AM  How to Invest in Healthcare Stocks the Easy Way Motley Fool
Jan-23-18 01:12PM  Vermont Legalizes Recreational Marijuana on January 22, 2018 Market Realist
Jan-18-18 10:30AM  A Look into Amgens Collaborations in 2H17 Market Realist
Nov-22-17 10:31AM  Mercks Immunology and Oncology Drugs, Post-3Q17 Market Realist
Nov-13-17 03:03PM  What Led to the Rise in the US Trade Deficit in September? Market Realist
Oct-30-17 12:25PM  Top 3 Pharmaceutical ETFs of 2017 Investopedia
Sep-12-17 07:37AM  How Mercks Diabetes Portfolio Performed in 2Q17 Market Realist
Sep-08-17 07:37AM  Why Jazz Pharmaceuticals Vyxeos Could Boost Revenue Growth in 2018 Market Realist
Sep-05-17 09:06AM  Eli Lilly & Co.s Recent Developments after Its 2Q17 Earnings Market Realist
Sep-01-17 10:37AM  Performance of Eli Lillys Endocrine Franchise in 2Q17 Market Realist
10:36AM  How Pfizers Enbrel and Xeljanz Are Positioned after 2Q17 Market Realist
07:36AM  Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders Market Realist
07:36AM  A Post-2Q17 Look at Pfizers Internal Medicines Market Realist
Aug-31-17 01:39PM  Why $475,000 isn't actually that expensive for Novartis's new drug Yahoo Finance
01:05PM  Why a $475,000 drug price tag isn't expensive Yahoo Finance Video
07:36AM  Bristol-Myers Squibbs Immunoscience Products in 2Q17 Market Realist
Aug-30-17 02:27PM  Trump can lower U.S. drug prices by fixing NAFTA Yahoo Finance
Aug-28-17 09:06AM  A Look into Mercks Immunology and Oncology Portfolio Market Realist
Aug-23-17 11:54AM  What Jazz Pharmaceuticals Expects for Vyxeos Market Realist
Aug-22-17 09:07AM  How Allergans US Specialized Therapeutics Segment Performed in 2Q17 Market Realist
07:37AM  Behind Xyrems Solid Demand Trends in 2017 Market Realist
07:36AM  Eliquis and Sprycel Could Boost BMYs Revenue Growth in 2H17 Market Realist
Aug-17-17 07:36AM  How Amgens Nephrology Drugs Are Positioned after 2Q17? Market Realist
Aug-10-17 10:36AM  Celgenes Abraxane Continued Steady Growth in 2Q17 Market Realist
Aug-07-17 09:45AM  Q2 Earnings Fail to Impress Pharma ETF Zacks
Aug-04-17 01:57PM  Valeant Pharmaceuticals Intl Inc (VRX) Stock: Stupid Is as Stupid Does InvestorPlace
Aug-01-17 10:41AM  How Gilead Sciences HCV Franchise Is Positioned after 2Q17 Market Realist
09:09AM  Dupixent Could Substantially Drive Regenerons Growth Market Realist
Jul-31-17 04:36PM  Examining Bristol-Myers Squibbs Oncology Portfolios 2Q17 Market Realist
07:40AM  Eli Lilly in 2Q17: Humulin and Endocrine Products Market Realist
Jul-28-17 07:36AM  Behind Pfizers Legacy Established Products Performance in 2017 Market Realist
Jul-14-17 10:37AM  Behind Allergans Business Segments and Revenues Market Realist
Jul-10-17 03:10PM  What Lies Ahead for Pharma ETFs in Second Half 2017 Zacks
10:37AM  How Bristol-Myers Squibb Stock Has Performed in 2Q17 Market Realist
Jul-07-17 12:00PM  Improving Health for This Pharma ETF Investopedia
Jul-05-17 09:06AM  Johnson & Johnsons Consumer Business in 1Q17 Market Realist
Jul-03-17 12:25PM  Gordon Gekko was right: Stocks are now a zero-sum game Yahoo Finance
10:37AM  How Did Keytruda Perform in 1Q17? Market Realist
Jun-30-17 01:44PM  Why the US is losing the war on drug prices: trader Yahoo Finance
11:37AM  Stocks edge up as Q2 draws to a close Yahoo Finance
Jun-29-17 08:00AM  Trending: OPEC Fails to Scare Oil Short-Sellers ETF Database
Jun-27-17 10:36AM  A Look at Pfizers Revenue for 1Q17 Market Realist
Jun-23-17 01:36PM  Why investors flipped 180 on health care stocks today: NYSE trader Yahoo Finance Video
May-30-17 02:02PM  How Johnson & Johnsons Valuation Changed Post-1Q17 Market Realist
May-24-17 10:36AM  Performance of Mercks Diabetes Portfolio in 1Q17 Market Realist
May-11-17 10:36AM  Understanding Allergans Valuation after the 1Q17 Results Market Realist
May-03-17 02:58PM  Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus Zacks
Apr-26-17 09:09AM  Bristol-Myers Squibbs 1Q17 Estimates: Virology Segment Market Realist
Apr-20-17 05:05PM  Johnson & Johnsons 1Q17 Segment-by-Segment Performance Market Realist
Apr-13-17 04:35PM  Johnson & Johnsons 1Q17 Estimates: Pharmaceuticals Segment Market Realist
Apr-11-17 07:36AM  Analyzing the Performance of Abbott Laboratories in 1Q17 Market Realist
Apr-07-17 06:59PM  ETF Flyers: Pharmaceuticals
03:05PM  Performance of Merck & Co. Stock in 1Q17 Market Realist
Apr-04-17 10:36AM  These Key Product Developments Could Help Pfizer Market Realist
10:36AM  These Key Product Developments Could Help Pfizer
Apr-03-17 10:37AM  Recent Developments at Eli Lilly Market Realist
10:37AM  Recent Developments at Eli Lilly
Mar-30-17 09:08AM  How Eli Lillys Business Segments Performed in 2016 Market Realist
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.